Literature DB >> 10825077

Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii.

M Niault1, F Thomas, J Prost, F H Ansari, P Kalfon.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10825077     DOI： 10.1086/517255

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Use of probiotics in gastrointestinal disorders: what to recommend?

Authors:  Elizabeth C Verna; Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

Review 2.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

3.  Saccharomyces boulardii fungemia caused by treatment with a probioticum.

Authors:  Julie Bjerre Thygesen; Henning Glerup; Britta Tarp
Journal:  BMJ Case Rep       Date:  2012-03-27

4.  Management and Prevention of Clostridium difficile-Associated Diarrhea.

Authors:  William P. Ciesla; David A. Bobak
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 5.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.

Authors:  Aloysius L D'Souza; Chakravarthi Rajkumar; Jonathan Cooke; Christopher J Bulpitt
Journal:  BMJ       Date:  2002-06-08

Review 6.  Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism.

Authors:  Marco Cassone; Pietro Serra; Francesca Mondello; Antonietta Girolamo; Sandro Scafetti; Eleonora Pistella; Mario Venditti
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

7.  Fatal Saccharomyces cerevisiae aortic graft infection.

Authors:  Davey Smith; David Metzgar; Christopher Wills; Joshua Fierer
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

Review 8.  Clostridium difficile Infection and Fecal Microbiota Transplant.

Authors:  Alyssa Liubakka; Byron P Vaughn
Journal:  AACN Adv Crit Care       Date:  2016-07

9.  Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.

Authors:  Beata Sulik-Tyszka; Emilian Snarski; Magda Niedźwiedzka; Małgorzata Augustyniak; Thorvald Nilsen Myhre; Anna Kacprzyk; Ewa Swoboda-Kopeć; Marta Roszkowska; Jadwiga Dwilewicz-Trojaczek; Wiesław Wiktor Jędrzejczak; Marta Wróblewska
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.